Evaluating the Role of Biosimilars in the Management of Rheumatologic Conditions

In this downloadable slideset, Stanley B. Cohen, MD, reviews the regulatory pathway and development of biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 21, 2017

In this downloadable slideset, Jonathan Kay, MD, explores key concepts including immunogenicity, switching, and interchangeability of biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 21, 2017

In this downloadable slideset, Kenneth G. Saag, MD, MSc, reviews the evidence supporting currently FDA-approved biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 15, 2017

Watch our recent quiz game on biosimilars in rheumatologic conditions.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: November 28, 2017 Expired: No longer available for credit